A Rare Liver Tumor Nodule
Chao Qu,Hang-yan Wang,Dian-rong Xiu
DOI: https://doi.org/10.1053/j.gastro.2021.05.064
IF: 29.4
2022-01-01
Gastroenterology
Abstract:Question: A 32-year-old woman incidentally presented with a hyperechogenic solid lesion about 1.2 cm in the left liver during her routine annually ultrasound surveillance examination for gallbladder stones 3 years earlier. The size of the mass slightly increased to 2.1 cm 1 year later and then to a 6-cm cystic solid mass on abdominal ultrasound 4 month before admission for treatment (Figure A, arrow). The patient did not have any symptoms of epigastric discomfort on admission and no history of other diseases except cholecystolithiasis. There was no family history of liver tumors. Laboratory studies showed the following results: alanine aminotransferase, 22 U/L; aspartate aminotransferase of 23 U/L; serum total bilirubin of 10.8 μmol/L; and serum albumin of 39 g/L. Alpha-fetoprotein, carcinoembryonic antigen, carbohydrate antigen 19-9, and carbohydrate antigen 12-5 were all within normal ranges. Virologic tests were negative for hepatitis B and C. An abdominal enhanced computed tomography scan (Figure B, arrow) and magnetic resonance imaging (Figure C, arrow) showed a lobulated cystic solid mass in the left liver and is closely related to the middle hepatic vein. On the contrast-enhanced scan, the cystic components showed no obvious enhancement, the solid part showed uneven enhancement, and the intrahepatic bile duct was slightly dilated. What is your diagnosis? See the Gastroenterology web site (www.gastrojournal.org) for more information on submitting your favorite image to Clinical Challenges and Images in GI. Because the mass increased in size relatively fast, the possibility of malignancy could not be excluded and was considered as the indication for resection. During the operation, a cystic solid mass in the left lobe was detected that closely related to the left hepatic pedicle and the middle hepatic vein, which could not be enucleated. Therefore, a laparoscopic left hepatectomy was performed with the intraglissonian approach to separate and transect the left port vein, left hepatic artery, and left hepatic duct. A frozen section showed the cut end of the left bile duct was negative. The excised specimen showed that the liver had a cyst with a size of about 6 cm, whose inner wall contained a solid papillary nodule about 3.8 cm, and there was a small amount of pancreatic tissue beside the nodule (Figure D, arrow). Under hematoxylin and eosin staining, an obvious papillary structure and oncocytic adenoma cytological features can be seen in the background of liver cells (Figure E), with severe dysplasia locally (Figure F) and a small amount of ectopic pancreatic acinar tissue nearby the solid mass (Figure G, arrow). Immunohistochemistry showed MUC-1(+), MUC-2(–), MUC-5AC(+), and MUC-6 (+). The final diagnosis of the liver mass was an intraductal papillary mucinous neoplasm (oncocytic type) arising from the ectopic pancreas (EP). The patient did well postoperatively and was discharged 7 days after the surgery. At follow-up 5 months after the operation, the patient remained well without sign of recurrence. EP is not uncommon; however, IPMNs arising from EP is rare. To our knowledge, there are only 14 cases reported,1Hisanaga E. Sano T. Kubo N. et al.Adenocarcinoma with intraductal papillary mucinous neoplasm arising in a duodenal heterotopic pancreas: a case report.Clin J Gastroenterol. 2020; 13: 1373-1382Crossref PubMed Scopus (2) Google Scholar including 4 cases complicated by malignancy (tumor diameter >3 cm, with mural nodules), and with an earlier age of malignant transformation than IPMNs in situ. IPMNs arising from EP is most occurring in the gastrointestinal tract (13 cases) and so far only 1 case has been found in the common hepatic duct. It is most commonly found incidentally at surgery, endoscopy, or during other investigations. Although most patients are asymptomatic, it can occasionally lead to gastrointestinal obstruction, obstructive jaundice, and other presentations, depending on the location of the abnormal tissue.2Patel N. Berzin T. Intraductal papillary mucinous neoplasm arising in a heterotopic pancreas: a case report.Am J Gastroenterol. 2010; 105: 2513-2514Crossref PubMed Scopus (11) Google Scholar In our case, it is the first report of the IPMNs arising from EP manifesting as liver tumor. This female patient had an early age of onset and the tumor with severe dysplasia locally, which is a specific manifestation of the oncocytic-type IPMN. In addition, the diameter of this liver mass was the largest and grew faster than in the other 14 cases reported, which may be because the tumor does not form a ductal route for cystic fluid excretion in the liver. For IPMNs arising from an EP, especially for patients who meet the important criteria for judging possible malignant transformation in the guidelines3Sugiyama M. Izumisato Y. Abe N. et al.Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas.Br J Surg. 2003; 90: 1244-1249Crossref PubMed Scopus (372) Google Scholar (presence of clinical symptoms, tumor diameter of >3 cm, with mural nodules), aggressive surgical intervention is recommended. Because the tumor is rare, preoperative diagnosis is difficult and intraoperative and postoperative pathologic diagnosis is usually required; thus, it is appropriate to choose a standardized radical resection.